Reproductive Health Project - Additional Financing (WB-P153104)

  • Burkina Faso
Where the impacts of the investment may be experienced.
Financial Institutions
  • World Bank (WB)
International, regional and national development finance institutions. Many of these banks have a public interest mission, such as poverty reduction.
Project Status
Bank Risk Rating
Risk rating varies among banks and may refer only to the particular investment and not to the risk for the project as a whole. Projects marked 'U' have an 'Unknown' risk rating at the time of disclosure.
Voting Date
Mar 15, 2016
The estimate day the bank will vote on a proposed investment. The decision dates may change, so review updated project documents or contact the EWS team.
Ministry of Finance and Budget
The holder of the loan, grant, or other investment.
  • Education and Health
The service or industry focus of the investment. A project can have several sectors.
Investment Amount (USD)
$ 35.00 million
Value listed on project documents at time of disclosure. If necessary, converted to USD$. Please review updated project documents for more information.
Project Cost (USD)
$ 35.00 million
Value listed on project documents at time of disclosure. If necessary, converted to USD$. Please see updated project documentation for more information.
Primary Source

Original disclosure @ WB website

Updated in EWS Sep 23, 2017

Disclosed by Bank Jan 20, 2016

Contribute Information
Can you contribute information about this project?
Contact the EWS Team

Project Description
The development objective of the Reproductive Health Project for Burkina Faso is to improve the utilization and quality of reproductive health services in the Recipient's territory, with a particular focus on selected regions of the Recipient. The additional financing (AF) will continue to support the provision of a package of health services through results-based financing (RBF) and the reinforcement of reproductive health services. In addition, the AF will: (a) support the implementation of a number of recommendations from the mid-term review (MTR) that was concluded in July 2015; (b) help finance the costs associated with the expansion of ongoing piloted strategies such as community-based targeting (CBT) of the poor and community-based health insurance (CBHI); (c) introduce interventions that will address the needs of population groups vulnerable to human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS); and (d) provide more time for the completion of the ongoing RBF impact evaluation. The AF will also fill the expected financing gap in resources needed to complete the RBF pilot and impact evaluation (IE) in 2017, in particular the added cost of the new interventions that aim to increase access of the poor to health services through RBF subsidies and incentives.
Investment Description
  • World Bank (WB)
Contact Information
Name: National AIDS Council (SP-CNLS) Contact: Coordinator Title: Coordinator Tel: (226) 5032-4188 Email: ACCOUNTABILITY MECHANISM OF WORLD BANK The World Bank Inspection Panel is the independent complaint mechanism and fact-finding body for people who believe they are likely to be, or have been, adversely affected by a World Bank-financed project. If you submit a complaint to the Inspection Panel, they may investigate to assess whether the World Bank is following its own policies and procedures for preventing harm to people or the environment. You can contact the Inspection Panel or submit a complaint by emailing You can learn more about the Inspection Panel and how to file a complaint at: